2018
DOI: 10.1016/j.clnu.2017.04.007
|View full text |Cite
|
Sign up to set email alerts
|

Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
45
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(53 citation statements)
references
References 29 publications
8
45
0
Order By: Relevance
“…Further studies that modulate the amount of RSF, notably weight loss are warranted [27], however, it will be difficult to tease out the specific effects of a reduction in RSF volume on renal function, when VAT and total body fat are concomitantly lowered. Furthermore, it will be interesting to measure proteins and cytokines that are secreted by RSF in different disease conditions such as obesity or T2D to better assess RSF function.…”
Section: Discussionmentioning
confidence: 99%
“…Further studies that modulate the amount of RSF, notably weight loss are warranted [27], however, it will be difficult to tease out the specific effects of a reduction in RSF volume on renal function, when VAT and total body fat are concomitantly lowered. Furthermore, it will be interesting to measure proteins and cytokines that are secreted by RSF in different disease conditions such as obesity or T2D to better assess RSF function.…”
Section: Discussionmentioning
confidence: 99%
“…The flow of the study selection procedure which followed the literature search is summarised in Figure 1 Table 2 . Five trials [45][46][47][48][49] did not include LDL-C as an outcome; ten trials [50][51][52][53][54][55][56][57][58][59] were performed on participants with Diabetes mellitus and/or CVD; eleven trials [60][61][62][63][64][65][66][67][68][69][70] had less than 100 randomised participants; three [71][72][73] had duration < 6 months; two trials 74,75 did not report on SD or 95% CI; seven trials [76][77][78][79][80][81][82] were irrelevant with inappropriate intervention; and one trial 83 was dismissed based on high attrition rate and high risk of bias.…”
Section: Literature Searchmentioning
confidence: 99%
“…Hu et al(2015) 45 McManus et al(2001) 46 Viegener et al(1990) 47 Zelicha et al(2017) 48 Blüher et al(2012) 138 D. mellitus and/or CVD Shai et al (2008) 50 Cardillo et al (2006) 51 Tsai et al (2005) 52 Stern et al (2004) 53 Dyson et al (2007) 54 Samaha et al (2003) 55 Yancy et al (2010) 56 Hu et al (2016) 57 Turer et al (2012) 58 Qi et al (2015) 59 <100 participants on start Lim et al (2010) 60 Das et al (2007) 61 Foster et al (2003) 62 Seshadri et al (2004) 63 Brehm et al (2003) 64 Keogh et al (2007) 65 Ebbeling et al (2007) 66 Bradley et al (2009) 67 Tay et al (2008) 68 Dansinger et al (2005) 69 Leichtle et al (2011) 70…”
Section: Reason For Exclusion Authors No Ldl-c Reportedmentioning
confidence: 99%
“…As perivascular fat depot it is in close contact with the adventitia of large, medium and small arteries and possesses unique features differing from other fat depots. Renal sinus fat is apparently directly linked to obesity [9] as well as liver function [10] and is thought to obstruct the blood and lymph outflow of the kidney, thus increasing parenchymal hydrostatic pressure leading to increasing organ volume [11]. Similarly, to other perivascular fat tissue particularly intrahepatic fat and visceral adipose tissue (VAT), it is associated with cardiovascular risk factors such as hypertension, diabetes and chronic kidney disease [11][12][13].…”
Section: Introductionmentioning
confidence: 99%